SCHEMBL31642347

SCHEMBL31642347

CC(C)(C)OC(=O)CCn1nc2n(c1=O)CCC2

nearest known ligand 0.43

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ KCNH2 Q12809 2/20 0.36
▸ SCN5A Q14524 2/20 0.36
▸ DHODH Q02127 2/20 0.33
▸ PREP P48147 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31642676 0.79 KCNH2 (0.38) KCNH2SCN5A
SCHEMBL14372289 0.71 KCNH2 (0.36) KCNH2SCN5A
SCHEMBL31710474 0.71 ALOX5 (0.42) KCNH2SCN5A
SCHEMBL9496530 0.70 HTT (0.38) KCNH2SCN5A
SCHEMBL1880519 0.69 ALDH1A1 (0.34) —
SCHEMBL3524929 0.68 KCNH2 (0.42) KCNH2SCN5A
SCHEMBL4133149 0.67 CNR1 (0.39) —
SCHEMBL9377290 0.67 KCNH2 (0.39) KCNH2SCN5A
SCHEMBL12013041 0.67 BRD4 (0.38) —
SCHEMBL22787170 0.67 TNF (0.30) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025137537-A1 COMPOSITIONS AND METHODS FOR TREATING MYC-MEDIATED DISEASES ARRAKIS THERAPEUTICS, INC. (US) 2025-06-26 — — WO disclosed
Send feedback